Chris Duke joins RBL LLC leadership team as Operating Partner [Yahoo! Finance]
Amicus Therapeutics, Inc. (FOLD)
Last amicus therapeutics, inc. earnings: 11/11 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amicusrx.com/investor-relations
Company Research
Source: Yahoo! Finance
rapidly building companies based on breakthrough medical technologies from leading research institutions, announced the appointment of Chris Duke as an operating partner. RBL LLC Logo (PRNewsfoto/RBL LLC) Duke, a seasoned biopharmaceutical executive and former CEO of Gennao Bio, brings extensive experience in rare diseases, gene therapy, global commercialization, and company building that will be instrumental in RBL's mission to accelerate lifesaving therapies from bench to bedside. "Securing a leader of Chris' caliber represents a significant addition to RBL," said Paul Wotton, RBL's managing partner. "Few executives possess his unique combination of scientific, operational, and commercial expertise. As we build multiple companies simultaneously, Chris' perspective on venture creation, global strategy, and company scaling will be invaluable in helping us identify and advance the most promising opportunities." "The Houston biotech ecosystem is evolving rapidly, with academic i
Show less
Read more
Impact Snapshot
Event Time:
FOLD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FOLD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FOLD alerts
High impacting Amicus Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FOLD
News
- Pombiliti (Amicus Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, Forecasts [Yahoo! Finance]Yahoo! Finance
- Genomenon and Amicus Therapeutics Partner to Advance Fabry Disease Awareness and Diagnosis [Yahoo! Finance]Yahoo! Finance
- How The Amicus Therapeutics (FOLD) Story Is Shifting Inside BioMarin's Rare Disease Portfolio [Yahoo! Finance]Yahoo! Finance
- Amicus Therapeutics Buyout Advances As Valuation Gap Draws Investor Focus [Yahoo! Finance]Yahoo! Finance
- Amicus Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
FOLD
Earnings
- 2/20/26 - Beat
FOLD
Sec Filings
- 3/4/26 - Form 4
- 3/3/26 - Form 8-K
- 3/2/26 - Form 144
- FOLD's page on the SEC website